Teen becomes first person saved by CRISPR base editing after leukaemia treatment
By
Alyssa Tapley
Summary
13-year-old Alyssa Tapley, diagnosed with leukaemia, was told she had only weeks to live after a failed bone marrow transplant. She became the first person to receive an experimental CRISPR base editing treatment at Great Ormond Street Hospital in London. The procedure, which involved editing immune cells to attack her cancer, saved her life. Now 15 and in remission, she shares her story of survival and the groundbreaking gene-editing therapy that transformed her prognosis.
Source
bskyTeen becomes first person saved by CRISPR base editing after leukaemia treatmentnewscientist.comKey quotes
· 5 pulledWhen the bone marrow transplant failed to treat my leukaemia, it was like: this is it, there's nothing else now.
The doctors were telling my parents it was a matter of weeks. Not years, not months, but weeks.
Oh my gosh, this is my last birthday. I'm never gonna grow up and have a family and do all the things that normal people are completely used to.
It was like sci-fi. They were like: 'Oh, we're gonna take your blood, edit it, and put it back in.'
I'm the first person whose life was saved by CRISPR base editing.
You might also wanna read
First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025
In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a ne
popularmechanics.com·6mo ago
Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time
For the first time, researchers have successfully implanted Crispr-edited pancreatic cells into a patient with type 1 diabetes. The gene-edi
wired.com·9mo ago
Using CRISPR-Cas9 for Trisomic Rescue in Down Syndrome Cells
The study demonstrates the use of CRISPR-Cas9 to achieve trisomy rescue by eliminating the target chromosome from human trisomy 21 cells.
academic.oup.com·11mo ago
The case for and against universal newborn DNA sequencing
A brief article about Freddie, a baby diagnosed with retinoblastoma (eye cancer) at four weeks old, who was successfully treated with chemot
economist.com·19h ago
New CRISPR Technique Selectively Destroys Cancer Cells with Common Mutation
Researchers at UC Berkeley, UCSF, and Gladstone Institutes have developed a novel CRISPR-based technique called "RNA-Triggered Chromatin Shr
innovativegenomics.org·18d ago
CRISPR's Limitations in Mitochondrial DNA Editing and Emerging Alternatives
The article discusses the limitations of CRISPR gene editing technology in accessing mitochondrial DNA (mtDNA) and the resulting challenges
nature.com·8mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.